Insider Transactions in Q4 2022 at Intercept Pharmaceuticals, Inc. (ICPT)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 31 2022	M Michelle Berrey President, R&D and CMO	SELL Payment of exercise price or tax liability	Direct	765 -1.09%	$9,180 $12.37 P/Share
Dec 31 2022	Jerome Benedict Durso CEO	SELL Payment of exercise price or tax liability	Direct	7,083 -6.36%	$84,996 $12.37 P/Share
Dec 31 2022	David A Ford Chief Human Resources Officer	SELL Payment of exercise price or tax liability	Direct	1,777 -6.25%	$21,324 $12.37 P/Share
Dec 31 2022	Jared Freedberg General Counsel	SELL Payment of exercise price or tax liability	Direct	718 -1.49%	$8,616 $12.37 P/Share
Dec 31 2022	Linda M Richardson EVP & Chief Commercial Officer	SELL Payment of exercise price or tax liability	Direct	1,600 -4.84%	$19,200 $12.37 P/Share
Dec 31 2022	Andrew Saik EVP & Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	718 -1.26%	$8,616 $12.37 P/Share
Dec 31 2022	Rocco Venezia Chief Accounting Officer	SELL Payment of exercise price or tax liability	Direct	675 -4.13%	$8,100 $12.37 P/Share
Dec 21 2022	Andrew Saik EVP & Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	908 -1.57%	$11,804 $13.43 P/Share
Dec 14 2022	M Michelle Berrey President, R&D and CMO	SELL Payment of exercise price or tax liability	Direct	1,246 -1.75%	$17,444 $14.94 P/Share
Nov 01 2022	Jared Freedberg General Counsel	SELL Payment of exercise price or tax liability	Direct	771 -1.57%	$11,565 $15.73 P/Share

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Value

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

Operation

Value

Type

Receive news related to INTERCEPT PHARMACEUTICALS, INC.